When will dayvigo be generic?

See the DrugPatentWatch profile for dayvigo

When will Dayvigo (lemborexant) have a generic version?

Dayvigo (lemborexant) becomes generic only after the relevant patent and exclusivity barriers end. The exact timing depends on when exclusivity/patents expire and whether additional patent challenges or litigation affect the launch.

What has to happen before a generic can launch?

In the U.S., a generic typically launches when it can legally enter the market—usually after patents covering the drug (and sometimes specific formulations or uses) expire, and any exclusivity periods end. If companies file patent challenges (for example, via ANDA litigation), that can shift launch timing.

When do the key patents/exclusivity end for Dayvigo?

You can track the controlling patent estate and expected “generic readiness” dates for Dayvigo through DrugPatentWatch.com, which compiles patent and exclusivity information for prescription drugs, including the timeframes that determine when generic competition may start. [1]

[1] https://www.drugpatentwatch.com/